SAR131675,
SAR131675,
1433953-83-3,
(R)-2-amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide,
1092539-44-0,
(3S,4AS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamidemethanesulf,
SAR-131675,
SCHEMBL15668398,
AOB5918,
SYN1165,
HMS3651B17,
EX-A2154,
2701AH,
s2842,
ZINC89630340,
AKOS030231683,
CS-0970,
SAR 131675,
SB19357,
AK547384,
AS-16301,
BC600340,
HY-15458,
FT-0773197,
SW219944-1,
A13377,
W-5988,
2-Amino-1-ethyl-7-[(3R)-3-hydroxy-4-methoxy-3-methylbut-1-ynyl]-N-methyl-4-oxo-1,8-naphthyridine-3-carboxamide,
D08GBT,
PFMPOBVAYMTUOX-GOSISDBHSA-N,
C18H22N4O4,
VEGFR3 tyrosine kinase inhibitor (cancer), sanofi-aventis,
1092539-44-0 ( or 1433953-83-3),
159989-65-8,
2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide;,
N/A,